Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
11276
CALL
Palvella Therapeutics
PVLA
$2.25B
| $93K | ﹤0.01% |
1,191
+250
| +27% | +$28.9K |
|
|
CGRN
11277
CALL
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $93K | ﹤0.01% |
69,900
+54,900
| +366% | +$96.6K |
|
11278
Orion Group Holdings
ORN
$402M
| $92.8K | ﹤0.01% |
35,815
+3,946
| +12% | +$11K |
|
11279
CALL
Dream Finders Homes
DFH
$1.42B
| $92.8K | ﹤0.01% |
7,000
+4,200
| +150% | +$49.6K |
|
|
VIOT
11280
Viomi Technology
VIOT
$47.2M
| $92.7K | ﹤0.01% |
90,042
+14,681
| +19% | +$17.9K |
|
|
MGIC
11281
PUT
DELISTED
Magic Software Enterprises
MGIC
| $92.7K | ﹤0.01% |
6,800
-40,400
| -86% | -$615K |
|
11282
PUT
Northwest Bancshares
NWBI
$2.31B
| $92.6K | ﹤0.01% |
7,700
+1,300
| +20% | +$17.6K |
|
11283
PUT
Quanex
NX
$962M
| $92.6K | ﹤0.01% |
4,300
+4,100
| +2,050% | +$98.4K |
|
11284
iShares MSCI Malaysia ETF
EWM
$330M
| $92.5K | ﹤0.01% |
+4,171
| New | +$94.3K |
|
|
INBX
11285
PUT
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $92.5K | ﹤0.01% |
4,900
-2,600
| -35% | -$60.5K |
|
|
QQQH
11286
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $92.4K | ﹤0.01% |
2,350
-16,300
| -87% | -$623K |
|
11287
CALL
Unisys
UIS
$209M
| $92.3K | ﹤0.01% |
23,800
-16,100
| -40% | -$77.8K |
|
11288
CALL
C4 Therapeutics
CCCC
$522M
| $92.3K | ﹤0.01% |
29,400
+19,800
| +206% | +$117K |
|
11289
PUT
AirSculpt Technologies
AIRS
$247M
| $92.2K | ﹤0.01% |
+18,300
| New | +$101K |
|
11290
CALL
Theravance Biopharma
TBPH
$881M
| $92.2K | ﹤0.01% |
8,500
-40,100
| -83% | -$424K |
|
|
USBC
11291
USBC Inc
USBC
$149M
| $92.2K | ﹤0.01% |
+2,589
| New | +$121K |
|
11292
CALL
Kartoon Studios
TOON
$37.4M
| $92K | ﹤0.01% |
33,700
-9,800
| -23% | -$44.6K |
|
11293
PUT
Outset Medical
OM
$84.8M
| $92K | ﹤0.01% |
333
+146
| +78% | +$53.6K |
|
11294
CALL
ICL Group
ICL
$7.16B
| $91.8K | ﹤0.01% |
13,500
+1,800
| +15% | +$13.3K |
|
11295
CALL
CPS Technologies
CPSH
$83.6M
| $91.7K | ﹤0.01% |
32,300
-3,200
| -9% | -$9.23K |
|
11296
Extreme Networks
EXTR
$3.2B
| $91.7K | ﹤0.01% |
4,796
-24,798
| -84% | -$458K |
|
11297
CALL
Jakks Pacific
JAKK
$294M
| $91.7K | ﹤0.01% |
+5,300
| New | +$99.4K |
|
11298
PUT
MeiraGTx Holdings
MGTX
$1.25B
| $91.5K | ﹤0.01% |
17,700
+15,300
| +638% | +$106K |
|
11299
CALL
A10 Networks
ATEN
$1.99B
| $91.4K | ﹤0.01% |
5,900
-10,000
| -63% | -$153K |
|
11300
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
| $91.4K | ﹤0.01% |
37,600
+34,000
| +944% | +$77.9K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.